Jasper Therapeutics, Inc. (JSPR)
NASDAQ: JSPR · IEX Real-Time Price · USD
21.11
+0.87 (4.30%)
Jul 22, 2024, 12:36 PM EDT - Market open
Jasper Therapeutics Employees
Jasper Therapeutics had 45 employees as of December 31, 2023. The number of employees increased by 10 or 28.57% compared to the previous year.
Employees
45
Change (1Y)
10
Growth (1Y)
28.57%
Revenue / Employee
n/a
Profits / Employee
-$1,420,733
Market Cap
313.03M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 45 | 10 | 28.57% |
| Dec 31, 2022 | 35 | 10 | 40.00% |
| Dec 31, 2021 | 25 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| OraSure Technologies | 638 |
| Adaptimmune Therapeutics | 449 |
| SOPHiA GENETICS | 430 |
| MacroGenics | 339 |
| Sutro Biopharma | 302 |
| Pulmonx | 279 |
| Nyxoah | 147 |
| Enanta Pharmaceuticals | 145 |
JSPR News
- 4 weeks ago - Jasper Therapeutics Announces Appointment of Svetlana Lucas Ph.D., to its Board of Directors - GlobeNewsWire
- 4 weeks ago - Jasper Therapeutics to Present at the Oppenheimer Novel Targets in Immunology Summit - GlobeNewsWire
- 5 weeks ago - Jasper Therapeutics Presents Data from Preclinical Briquilimab Study at the 2024 EHA Hybrid Congress - GlobeNewsWire
- 7 weeks ago - Jasper Therapeutics to Present Data on Briquilimab in Mast Cell Driven Diseases at the EAACI Congress 2024 - GlobeNewsWire
- 7 weeks ago - Jasper Therapeutics to Present at the Jefferies Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Jasper Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Developments - GlobeNewsWire
- 2 months ago - Jasper Therapeutics Announces Briquilimab Development Program in Asthma - GlobeNewsWire
- 2 months ago - Jasper Therapeutics to Present at Upcoming Investor Conferences in May - GlobeNewsWire